BeyondSpring is trading 22.74% up at $0.63, with no clear company-specific catalyst identified.

  • A midday market-movers report noted shares up 10.31% to $0.57, but gave no reason for the gain.
  • The company’s latest major announcement was the September 29 FDA Fast Track designation and DUBLIN-4 trial financing transaction; there was no new announcement on October 30.